Device Trial Radar · NCT07338708
Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus
Last checked: Nov 20, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Sep 17, 2024
Primary completion
May 13, 2025
Study completion May 13, 2025
Sponsor
- Lead sponsor
- Azienda Ospedaliera Universitaria Integrata VeronaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 14, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the Vivity Extended Depth of Focus intraocular lens works to improve vision in adults with cataracts and early-stage keratoconus. It will also learn about the safety and tolerance of this premium lens in patients with mild corneal irregularities. The main questions it aims to answer are: * Does the Vivity EDOF lens provide good distance vision (20/25 or better) in the dominant eye at 3 months after surgery? * Does it improve vision at intermediate and near distances compared to before surgery? * Does it preserve contrast sensitivity and optical quality despite mild corneal irregularities? * What is the patient-reported quality of life and satisfaction after implantation? * What visual disturbances (such as halos) do participants experience? All participants will: * Receive the Vivity EDOF intraocular lens (or its toric version if astigmatism is present) in both eyes during standard cataract surgery, with the second eye operated within 7 days; * Undergo comprehensive eye examinations before surgery including vision testing, corneal imaging, and optical quality measurements; * Attend a follow-up visit at 3 months after surgery for detailed vision testing at multiple distances, contrast sensitivity testing under different lighting conditions, halo assessment, and quality-of-life questionnaires.
Conditions
- Cataract
- Keratoconic Subjects
Interventions
Extended Depth of Focus Intraocular Lens ImplantationDevice
Bilateral implantation of the AcrySof IQ Vivity (Alcon, Fort Worth, TX, USA) Extended Depth of Focus (EDOF) intraocular lens during phacoemulsification cataract surgery. The Vivity is a single-piece hydrophobic acrylic IOL (6.0 mm optic, 13.0 mm overall length) featuring non-diffractive X-WAVE wavefront-shaping technology with a slightly elevated central plateau (\~1 µm) and surrounding curvature modulation to extend focal range. It incorporates UV and blue light filtering with refractive index 1.55 at 35°C. The spherical model (powers +15.0 D to +25.0 D) or toric model (cylinder 1.03 D to 4.11 D at IOL plane) is selected based on corneal astigmatism. IOL power calculated using Kane formula targeting emmetropia. Surgery performed with 2.2 mm incision under topical anesthesia, with second-eye surgery within 7 days. This study specifically evaluates performance in patients with early-stage stable keratoconus.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Distance-Corrected Visual Acuity in the Dominant EyeTime frame: 3 months after surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Azienda Ospedaliera Integrata di Verona
Verona, Verona, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.